![Patricia Morel-Mandrino](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Patricia Morel-Mandrino
No más puestos en curso
Historial de carrera de Patricia Morel-Mandrino
Antiguos cargos conocidos de Patricia Morel-Mandrino.
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
Quidel Corp.
![]() Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Director Técnico/Científico/I+D | - | - |
TXCELL | Director Técnico/Científico/I+D | 18/11/2009 | - |
Corporate Officer/Principal | 17/11/2009 | 18/11/2009 |
Estadísticas
Internacional
Francia | 2 |
Estados Unidos | 2 |
Operativa
Chief Tech/Sci/R&D Officer | 2 |
Corporate Officer/Principal | 1 |
Sectorial
Commercial Services | 2 |
Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Sangamo Therapeutics France SAS
![]() Sangamo Therapeutics France SAS Miscellaneous Commercial ServicesCommercial Services Sangamo Therapeutics France SAS is a biotechnology company, which engages in developing platforms for T cell immunotherapies for the treatment of severe inflammatory and autoimmune diseases. The company was founded on April 12, 2001, and is headquartered in Valbonne-Sophia Antipolis, France. | Commercial Services |
Quidel Corp.
![]() Quidel Corp. Medical SpecialtiesHealth Technology Quidel Corp. engages in the development, manufacture and market of rapid diagnostic testing solutions. Its portfolio includes rapid immunoassays, cardiac immunoassays, specialized diagnostic solutions and molecular diagnostic solutions. The firm products are directly sold to end users and distributors and for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies and wellness screening centers. The company was founded in 1979 and is headquartered in San Diego, CA. | Health Technology |